Advertisement

Topics

Bleeding control drug Nuwiq gains FDA approval for new product strengths

05:07 EDT 24 Aug 2017 | SmartBrief

The FDA granted approval for new product strengths for Octapharma's Nuwiq, a recombinant factor VIII treatment for patients w -More

Original Article: Bleeding control drug Nuwiq gains FDA approval for new product strengths

NEXT ARTICLE

More From BioPortfolio on "Bleeding control drug Nuwiq gains FDA approval for new product strengths"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Drug Approvals
In order to become availible to pateints, drugs need to undergo a number of phases of clinical trials to test their efficacy and safty and to then be authorised by the drug approval organistion in each respective country. This is the FDA in the USA and N...

Recombinant DNA
Recombinant DNA is the formation of a novel DNA sequence by the formation of two DNA strands. These are taken from two different organisms. These recombinant DNA molecules can be made with recombinant DNA technology. The procedure is to cut the DNA of ...